Analysts Set Afya Limited (NASDAQ:AFYA) Target Price at $17.30

Shares of Afya Limited (NASDAQ:AFYA) have been assigned a consensus recommendation of “Hold” from the eight analysts that are currently covering the stock, Marketbeat reports. Seven equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $17.30.

Several analysts recently commented on the company. Bank of America cut Afya from a “buy” rating to a “neutral” rating and lowered their target price for the company from $22.00 to $17.00 in a research report on Tuesday, February 24th. Sanford C. Bernstein upgraded Afya to a “market perform” rating in a research report on Friday, January 16th. Wall Street Zen raised Afya from a “buy” rating to a “strong-buy” rating in a research note on Saturday. JPMorgan Chase & Co. reissued a “neutral” rating and set a $22.00 price target (down from $24.50) on shares of Afya in a report on Wednesday, January 7th. Finally, Zacks Research upgraded shares of Afya from a “strong sell” rating to a “hold” rating in a research note on Monday, March 9th.

Key Headlines Impacting Afya

Here are the key news stories impacting Afya this week:

• Positive Sentiment: EPS beat — Afya reported $0.41 EPS for 4Q25, topping consensus estimates and last year’s EPS, signaling stronger profitability per share which supports valuation metrics. Afya (AFYA) Tops Q4 Earnings Estimates
• Positive Sentiment: Large cash return — the Board approved a R$307.4 million dividend (~40% of consolidated net income), which is supportive for income-focused shareholders and may attract yield-seeking demand. Afya Limited Announces Dividend Distribution of R$307.4 Million
• Neutral Sentiment: Management commentary/transcript available — the full Q4 2025 earnings call transcript provides additional color on growth drivers, margins and capital allocation; investors should review management’s remarks on enrollment trends and clinic operations. Afya Limited (AFYA) Q4 2025 Earnings Call Transcript
• Negative Sentiment: Revenue miss — Afya reported 4Q revenue of BRL147.08 million (reported in USD-equivalent headlines), materially below analyst expectations, raising questions about enrollment or service revenue pacing that could pressure near-term growth. Afya Limited Announces Fourth Quarter and Twelve Months 2025 Financial Results
• Negative Sentiment: FY‑2026 revenue guidance slightly below consensus — the company updated FY‑2026 revenue guidance to a range (~R$731.7M–R$759.5M in the entry) that sits under the street’s ~$764M consensus, introducing downside risk to growth expectations; EPS guidance detail was unclear in the release. Afya Limited Announces Fourth Quarter and Twelve Months 2025 Financial Results

Afya Trading Up 1.9%

Afya stock opened at $13.76 on Monday. Afya has a 52-week low of $13.00 and a 52-week high of $19.90. The company has a quick ratio of 0.98, a current ratio of 2.20 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of $1.29 billion, a price-to-earnings ratio of 9.42, a PEG ratio of 0.61 and a beta of 0.52. The firm has a 50-day moving average price of $14.39 and a two-hundred day moving average price of $14.76.

Afya (NASDAQ:AFYA) last announced its quarterly earnings results on Thursday, March 12th. The company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.36 by $0.05. The company had revenue of $147.08 million for the quarter, compared to analyst estimates of $174.74 million. Afya had a net margin of 20.31% and a return on equity of 18.77%. Sell-side analysts expect that Afya will post 1.52 earnings per share for the current year.

Institutional Trading of Afya

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Daiwa Securities Group Inc. acquired a new stake in shares of Afya in the 4th quarter worth approximately $43,000. Militia Capital Partners LP acquired a new position in shares of Afya during the second quarter valued at approximately $71,000. Quantbot Technologies LP bought a new stake in Afya during the second quarter worth approximately $117,000. State of Wyoming bought a new stake in Afya during the second quarter worth approximately $164,000. Finally, Quadrature Capital Ltd acquired a new stake in Afya in the second quarter worth approximately $181,000. 88.02% of the stock is currently owned by institutional investors.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.